STEROID-REFRACTORY

作品数：11被引量：26H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关作者：张洪明程坚金楠陈润哲更多>>
相关机构：华中科技大学东南大学苏州大学更多>>
相关期刊：《World Journal of Gastroenterology》《World Journal of Gastrointestinal Pharmacology and Therapeutics》《World Journal of Clinical Oncology》《China Medical Abstracts(Internal Medicine)》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Four-Year Maintenance Therapy with Cyclosporin A for Patients with Steroid-Refractory Idiopathic Minimal Change Disease Allergic to Rituximab
《Open Journal of Nephrology》2024年第4期538-544,共7页Kamel El-Reshaid Shaikha Al-Bader Hossameldin Tawfik Sallam John Patrick Madda 
Background: Patients with Steroid-Refractory Idiopathic Minimal change disease (SRIM) have high morbidity and mortality and inherent side effects of immunosuppressive therapy. Except for its cost, R has been shown to ...
关键词：CORTICOSTEROIDS Cyclosporin A RITUXIMAB Nephrotic Syndrome Minimal Change Disease Maintenance Therapy 
Efficacy of basiliximab in the treatment of 87 cases of steroid-refractory or steroid-dependent acute graft-versus-host disease
《China Medical Abstracts(Internal Medicine)》2022年第2期121-122,共2页HE Zhenxin 
Objective To evaluate the efficacy and prognosis of basiliximab in the treatment of steroid-refractory or steroid-dependent acute graft-versus-host disease (SR/SDaGVHD) after allogeneic hematopoietic stem cell transpl...
关键词：BLOOD INTESTINE ACUTE 
Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis被引量：4
《World Journal of Gastroenterology》2021年第12期1194-1212,共19页Masahiro Iizuka Takeshi Etou Yosuke Shimodaira Takashi Hatakeyama Shiho Sagara 
BACKGROUND It is a crucial issue for patients with refractory ulcerative colitis(UC),including steroid-dependent and steroid-refractory patients,to achieve and maintain steroid-free remission.However,clinical studies ...
关键词：Ulcerative colitis CYTAPHERESIS Steroid-dependent STEROID-REFRACTORY Steroid-free remission Inflammatory bowel disease 
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
《World Journal of Clinical Oncology》2019年第10期350-357,共8页Manreet Randhawa Gregory Gaughran Christine Archer Paul Pavli Adrienne Morey Sayed Ali Desmond Yip 
BACKGROUND Dual checkpoint inhibition improves response rates in treatment naive patients with metastatic melanoma compared to monotherapy.However,it confers a higher rate of toxicity,including immune-related colitis....
关键词：IPILIMUMAB Nivolumab Metastatic melanoma STEROID-REFRACTORY COLITIS Infliximab-refractory COLITIS Vedolizumab Case report 
Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis被引量：2
《World Journal of Gastroenterology》2019年第13期1603-1617,共15页Peter Hoffmann Cyrill Wehling Johannes Krisam Jan Pfeiffenberger Nina Belling Annika Gauss Department of 
BACKGROUND Acute severe ulcerative colitis unresponsive to systemic steroid treatment is a lifethreatening medical condition requiring hospitalization and often colectomy.Despite the increasing choice of medical thera...
关键词：Acute severe ULCERATIVE colitis STEROID-REFRACTORY TACROLIMUS Rescue therapy CALCINEURIN inhibitor Inflammatory BOWEL disease HOSPITALIZED 
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report被引量：1
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2019年第1期29-34,共6页Ammar B Nassri Valery Muenyi Ahmad AlKhasawneh Bruno De Souza Ribeiro James S Scolapio Miguel Malespin Silvio W de Melo Jr 
BACKGROUND A variety of immune-modulating drugs are becoming increasingly used for various cancers. Despite increasing indications and improved efficacy, they are often associated with a wide variety of immune mediate...
关键词：COLITIS INFLIXIMAB BIOLOGICS Immune mediated ADVERSE events IPILIMUMAB Nivolumab Case report 
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis被引量：8
《World Journal of Gastroenterology》2017年第11期2023-2028,共6页Animesh Jain Evan J Lipson William H Sharfman Steven R Brant Mark G Lazarev 
AIM To investigate management of patients who develop ipilimumab-mediated enterocolitis, including association of endoscopic findings with steroid-refractory symptoms and utility of infliximab as second-line therapy.M...
关键词：IPILIMUMAB Melanoma ENTEROCOLITIS Colitis Infliximab CORTICOSTEROID Colonic ulcer 
Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis被引量：3
《World Journal of Gastroenterology》2015年第1期254-261,共8页Nobuyuki Miyake Takafumi Ando Kazuhiro Ishiguro Osamu Maeda Osamu Watanabe Yutaka Hirayama Keiko Maeda Kazuhiro Morise Masanobu Matsushita Kazuhiro Furukawa Kohei Funasaka Masanao Nakamura Ryoji Miyahara Naoki Ohmiya Hidemi Goto 
AIM: To evaluate long-term prognosis following cyclosporine treatment by examining the rate of surgery avoidance among cyclosporine responders.METHODS: We retrospectively reviewed clinical records for 29 patients diag...
关键词：ULCERATIVE COLITIS CYCLOSPORINE Maintenance therap 
Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab被引量：1
《World Journal of Gastroenterology》2013年第4期590-593,共4页Ileana Duca Patricia Ramírez de la Piscina Silvia Estrada Rosario Calderón Katerina Spicakova Leire Urtasun Carlos Marra-López Salvador Zabaleta Raquel Bengoa María Asunción Marcaide Francisco García-Campos 
Primary sclerosing cholangitis is an infrequent extraintestinal manifestation of ulcerative colitis.Damage to bile ducts is irreversible and medical therapies to prevent progression of the disease are usually ineffect...
关键词：ULCERATIVE colitis INFLIXIMAB Monoclonal antibodies SCLEROSING CHOLANGITIS Bile duct diseases Tumor necrosis FACTOR-ALPHA 
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis被引量：2
《World Journal of Gastroenterology》2011年第14期1831-1835,共5页Valeria D'Ovidio Donatella Meo Angelo Viscido Giampaolo Bresci Piero Vernia Renzo Caprilli 
AIM:To identify factors predicting the clinical response of ulcerative colitis patients to granulocyte-monocyte apheresis (GMA). METHODS:Sixty-nine ulcerative colitis patients (39 F,30 M) dependent upon/refractory to ...
关键词：Granulocyte-monocyte apheresis Ulcerative colitis Steroid therapy Long-term follow-up Predictive factors 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部